Prolinamide derivatives as sodium channel modulators

Details for Australian Patent Application No. 2006301470 (hide)

Owner Convergence Pharmaceuticals Limited

Inventors Bergauer, Markus; Alvaro, Giuseppe; Giovannini, Riccardo; Profeta, Roberto

Agent Davies Collison Cave

Pub. Number AU-B-2006301470

PCT Pub. Number WO2007/042239

Priority 0520581.0 10.10.05 GB; 0523045.3 11.11.05 GB; 0618336.2 18.09.06 GB; 0603900.2 27.02.06 GB

Filing date 6 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 14 June 2012

International Classifications

C07D 207/22 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/401 (2006.01) - Proline

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/042239 Priority application(s): WO2007/042239

31 May 2012 Assignment before Grant

  Glaxo Group Limited The application has been assigned to Convergence Pharmaceuticals Limited

14 June 2012 Application Accepted

  Published as AU-B-2006301470

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301471-Quaternary alpha-aminocarboxamide derivatives as modulators of voltagegated sodium channels

2006301466-Controlling reproduction of audio data